The Bulletin
The Times


.

MedAlliance SELUTION SLR Receives Second FDA IDE Approval

  • Written by PR Newswire
MedAlliance SELUTION SLR Receives Second FDA IDE Approval

GENEVA, Aug. 10, 2022 /PRNewswire/ -- SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of occlusive disease of the superficial femoral artery (SFA).

MedAlliance SELUTION SLR Receives Second FDA IDE ApprovalMedAlliance SELUTION SLR Receives Second...
hacklink zlibraryzlibraryz-libraryMultiwinbetpipo güncel giriş1xbetjojobetcasibomcasibomjojobettaraftarium24taraftariummeritkinghacklink paneljojobetvsf watchesjojobetuk casinos not on gamstopGamStopcasino siteleri